132
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation of GHSR and GHRL Methylation in Colorectal Cancer

, , , &
Pages 1525-1539 | Received 22 Feb 2018, Accepted 01 Jun 2018, Published online: 02 Jul 2018

References

  • Torre LA , BrayF , SiegelRL , FerlayJ , Lortet-TieulentJ , JemalA . Global cancer statistics 2012 . CA Cancer J. Clin.65 ( 2 ), 87 – 108 ( 2015 ).
  • Coppedè F . The role of epigenetics in colorectal cancer . Expert Rev. Gastroenterol. Hepatol.8 ( 8 ), 935 – 948 ( 2014 ).
  • Lao VV , GradyWM . Epigenetics and colorectal cancer . Nat. Rev. Gastroenterol. Hepatol.8 ( 12 ), 686 – 700 ( 2011 ).
  • El Bairi K , TariqK , HimriIet al. Decoding colorectal cancer epigenomics . Cancer Genet.220 , 49 – 76 ( 2018 ).
  • Song L , PengX , LiYet al. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening . Epigenomics9 ( 5 ), 599 – 610 ( 2017 ).
  • Porcellini E , LaproviteraN , RiefoloM , RavaioliM , GarajovaI , FerracinM . Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications . Cancer Lett.419 , 84 – 95 ( 2018 ).
  • Moskalev EA , JandaghiP , FallahMet al. GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers . Oncotarget6 ( 6 ), 4418 – 4427 ( 2015 ).
  • Ordway JM , BudimanMA , KorshunovaYet al. Identification of novel high-frequency DNA methylation changes in breast cancer . PLoS ONE2 ( 12 ), e1314 ( 2007 ).
  • Botla SK , GholamiAM , MalekpourMet al. Diagnostic values of GHSR DNA methylation pattern in breast cancer . Breast Cancer Res. Treat.135 ( 3 ), 705 – 713 ( 2012 ).
  • de Groot JS , PanX , MeeldijkJ , van der WallE , van DiestPJ , MoelansCB . Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short report . Cell Oncol. (Dordr.)37 ( 4 ), 297 – 303 ( 2014 ).
  • Verlaat W , SnijdersPJF , NoviantiPWet al. Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer . Clin. Cancer Res.23 ( 14 ), 3813 – 3822 ( 2017 ).
  • Daugaard I , DominguezD , KjeldsenTE , KristensenLS , HagerH , WojdaczTK , HansenLL . Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma . Sci. Rep.6 , 35807 ( 2016 ).
  • Nakagawa T , MatsusakaK , MisawaKet al. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer . Cancer Lett.407 , 21 – 31 ( 2017 ).
  • Lin TC , HsiaoM . Ghrelin and cancer progression . Biochim. Biophys. Acta1868 ( 1 ), 51 – 57 ( 2017 ).
  • Nikolopoulos D , TheocharisS , Moutsios-RentzosA , KouraklisG , KostakisA . The role of serum total ghrelin level elevation in colon cancer patients . J. BUON.19 ( 2 ), 388 – 393 ( 2014 ).
  • D’Onghia V , LeonciniR , CarliRet al. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI . Biomed. Pharmacother.61 ( 2–3 ), 137 – 141 ( 2007 ).
  • Waseem T , Javaid-Ur-Rehman , AhmadF , AzamM , QureshiMA . Role of ghrelin axis in colorectal cancer: a novel association . Peptides29 ( 8 ), 1369 – 1376 ( 2008 ).
  • Murphy G , CrossAJ , DawseySMet al. Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study . Gut.67 ( 9 ), 1646 – 1651 ( 2018 ).
  • Sundkvist A , MyteR , PalmqvistR , HarlidS , Van GuelpenB . Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer . Gut doi:10.1136/gutjnl-2018-316110 ( 2018 ) ( Epub ahead of print ).
  • Fang XY , XuWD , HuangQet al. 5,10-Methylenetetrahydrofolate reductase polymorphisms and colon cancer risk: a meta-analysis . Asian Pac. J. Cancer Prev.15 ( 19 ), 8245 – 8250 ( 2014 ).
  • Mokarram P , NaghibalhossainiF , Saberi FirooziMet al. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status . World J. Gastroenterol.14 , 3662 – 3671 ( 2008 ).
  • Coppedè F , MigheliF , LopomoAet al. Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism . Epigenetics9 ( 4 ), 621 – 633 ( 2014 ).
  • Wettergren Y , OdinE , CarlssonG , GustavssonB . MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer . Mol. Med.16 ( 9–10 ), 425 – 432 ( 2010 ).
  • Coppedè F , GrossiE , LopomoA , SpisniR , BuscemaM , MiglioreL . Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer . Epigenomics7 ( 2 ), 175 – 186 ( 2015 ).
  • Eklöf V , Van GuelpenB , HultdinJ , JohanssonI , HallmansG , PalmqvistR . The reduced folate carrier (RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T polymorphisms and the risk of colorectal cancer: a nested case-referent study . Scand. J. Clin. Lab. Invest.68 ( 5 ), 393 – 401 ( 2008 ).
  • Yang YC , WuGC , JinL , WangKL , BaiZG , WangJ , ZhangZT . Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis . Pharmacogenomics J.17 ( 3 ), 265 – 273 ( 2017 ).
  • Khoram-Abadi KM , Forat-YazdiM , KheirandishSet al. DNMT3B −149 C>T and −579 G>T polymorphisms and risk of gastric and colorectal cancer: a meta-analysis . Asian Pac. J. Cancer Prev.17 ( 6 ), 3015 – 3020 ( 2016 ).
  • Naghibalhossaini F , MokarramP , KhaliliE , NaghibalhossainiS . DNMT3b-149C/T promoter variants and methylation of colorectal cancer-associated genes . Cancer Biomark.15 ( 3 ), 227 – 233 ( 2015 ).
  • Cohen R , BuhardO , CerveraPet al. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency . Eur. J. Cancer86 , 266 – 274 ( 2017 ).
  • Wojdacz TK , DobrovicA , HansenLL . Methylation-sensitive high-resolution melting . Nat. Protoc.3 ( 12 ), 1903 – 1908 ( 2008 ).
  • Li LC , DahiyaR . MethPrimer: designing primers for methylation PCRs . Bioinformatics18 ( 11 ), 1427 – 1431 ( 2002 ).
  • Migheli F , StoccoroA , CoppedèFet al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation . PLoS ONE8 ( 1 ), e52501 ( 2013 ).
  • Lien GS , LinCH , YangYL , WuMS , ChenBC . Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways . Eur. J. Pharmacol.776 , 124 – 131 ( 2016 ).
  • Bonfili L , CuccioloniM , CecariniVet al. Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction . Apoptosis18 ( 10 ), 1188 – 1200 ( 2013 ).
  • Kawaguchi M , KanemaruA , FukushimaTet al. Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice . Cancer Sci.106 ( 9 ), 1130 – 1136 ( 2015 ).
  • Sakai E , NakajimaA , KanedaA . Accumulation of aberrant DNA methylation during colorectal cancer development . World J. Gastroenterol.20 ( 4 ), 978 – 987 ( 2014 ).
  • Hu W , YangY , LiXet al. Multi-omics approach reveals distinct differences in left- and right-sided colon cancer . Mol. Cancer Res. doi:10.1158/1541-7786.MCR-17-0483 ( 2017 ) ( Epub ahead of print ).
  • Sugai T , YoshidaM , EizukaMet al. Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa . Clin. Epigenetics9 , 55 ( 2017 ).
  • Vymetalkova V , VodickaP , PardiniBet al. Epigenome-wide analysis of DNA methylation reveals a rectal cancer-specific epigenomic signature . Epigenomics8 ( 9 ), 1193 – 1207 ( 2016 ).
  • Menigatti M , TruningerK , GebbersJO , MarbetU , MarraG , SchärP . Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters . Oncogene28 , 899 – 909 ( 2009 ).
  • Ramirez N , BandresE , NavarroAet al. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions . Eur. J. Cancer44 ( 17 ), 2689 – 2695 ( 2008 ).
  • Krakowczyk L , StrzelczykJK , AdamekBet al. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa . Med. Sci. Monit.14 ( 10 ), BR219 – 25 ( 2008 ).
  • Alonso S , DaiY , YamashitaKet al. Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African–Americans . Oncotarget6 ( 5 ), 3420 – 3431 ( 2015 ).
  • Burgio E , MiglioreL . Towards a systemic paradigm in carcinogenesis: linking epigenetics and genetics . Mol. Biol. Rep.42 ( 4 ), 777 – 790 ( 2015 ).
  • Noreen F , RöösliM , GajPet al. Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle . J. Natl Cancer Inst.106 ( 7 ), ( 2014 ).
  • Li Y , TollefsbolTO . Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases . Epigenomics8 ( 12 ), 1637 – 1651 ( 2016 ).
  • Coppedè F . Epigenetic biomarkers of colorectal cancer: focus on DNA methylation . Cancer Lett.342 ( 2 ), 238 – 247 ( 2014 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.